Regulus Therapeutics
RGLS
#6949
Rank
$0.56 B
Marketcap
$8.16
Share price
0.00%
Change (1 day)
436.84%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: $0.56 Billion USD

As of December 2025 Regulus Therapeutics has a market cap of $0.56 Billion USD. This makes Regulus Therapeutics the world's 6949th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025$0.56 B460.08%
2024$0.10 B289.68%
2023$25.88 M12.2%
2022$23.07 M-49.82%
2021$45.98 M-46.37%
2020$85.73 M358.29%
2019$18.7 M127.96%
2018$8.2 M-92.41%
2017$0.10 B-9.21%
2016$0.11 B-74.07%
2015$0.45 B-41.5%
2014$0.78 B154.23%
2013$0.30 B36.8%
2012$0.22 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
$97.71 B 17,196.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
$120.89 B 21,299.92%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
$26.59 B 4,607.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$279.60 B 49,392.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
$60.52 B 10,613.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
$0.16 B-70.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$106.16 B 18,691.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
$2.97 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA